Indeed, aromatase-mediated accelerated aromatization of testosterone to estradiol might also have an impact on the development of CAD (33, 34), since testosterone supplementation greatly improved insulin resistance and reduced the risk of CAD (35, 36). The gene discussed is CYP19A1; the disease is coronary artery disorder.